Which country are Osstem implants from?

According to Osstem's own timeline, the company was founded in 1997 under the name D&D System. In its early years it developed practice management software for dentists; in 2000 it opened an implant training centre, in 2002 it set up an implant research institute, and in the same year it received FDA approval in the USA. In 2007 it began trading on the Korean KOSDAQ stock exchange. Its founder and long-time chairman is Choi Kyu-ok; the company's head office is in Seoul.

Growth quickly spread abroad. Osstem set up a subsidiary in Germany (Eschborn) in 2005, and by 2006 had subsidiaries in 12 countries. According to the company's 2025 information, it now has 33 overseas subsidiaries in 37 countries, and its 2024 sales were 960 million dollars. In Turkey the brand is represented under the name Osstem Implant Türkiye, which has a Turkish-language website.

Manufacturing is no longer limited to one country. According to a statement by the company dated March 2026, its facilities in South Korea, the USA, China and Brazil produce more than 22 million implant sets a year. The Yancheng facility in China opened in 2019; the Brazilian arm was added in 2024 with the acquisition of a Brazilian manufacturer called Implacil. Osstem's Turkish website, however, states that the manufacturing facilities for products in the country are in South Korea. The label on the box shows most definitively where the product you are given was made.

This is where the name Hiossen comes in. According to Hiossen's own website, the company was set up by Osstem in 2006 in the US state of Pennsylvania and took the name Hiossen Implant in 2007. All Hiossen implants are made and packaged in Pennsylvania. So if the card for an implant fitted in the USA says Hiossen, it is not a separate brand but the American branch of the Osstem family. On Osstem's European website, the line called ET is also offered with Hiossen's NH surface.

Ownership changed in 2023. According to a report in the Korean business press, in January 2023 the investment funds MBK Partners and Unison Capital Korea launched a tender offer of up to 2.1 trillion won to take management control of Osstem. According to the same publication's report from March 2023, the funds' stake rose to 83.34 per cent after the first tender, and a second tender was opened to take the company off the stock exchange. The founder, Choi Kyu-ok, signed an agreement to sell around half of his 20.6 per cent stake, and was expected to remain the second-largest shareholder after the sale. The same report states that Osstem, with a market share of 45 per cent in South Korea, 33 per cent in China and 8 per cent worldwide, is the largest implant manufacturer in both of these countries.

Osstem is not a single implant but a family. TS, as the manufacturer describes it, is a self-tapping, double-threaded line placed at bone level and presented as one of the most widely used implants in the world; it is offered with different surfaces such as SA, BA and SOI. KS and ET are also bone-level lines. SS is a one-stage line that sits at gum level and does not need a second surgical stage; it comes in two forms, the straight-bodied SS II and the slightly tapered SS III, with two platforms of 4.8 and 6.0 millimetres. MS is a family of thin one-piece implants designed for narrow bony ridges, denture retention and temporary use.

These differences within the same brand do not stay on paper. A laboratory study published in 2025 compared Osstem's TSIII and KSIII systems with different abutment screw designs. After repeated loading, the loss of screw tightness in TSIII ranged from 36.5 to 51.8 per cent depending on the tightening torque; in KSIII it stayed below 25 per cent at every torque level. This is a laboratory result, and the authors state that clinical confirmation is needed; but it shows that saying 'Osstem' is not enough to tell you how the screw will behave.

The practical consequence is this: if your card just says 'Osstem', that is not enough for a dentist who wants to replace a loose screw. Is it TS, KS or SS; which diameter and platform; which surface? Names that come up often in searches, such as 'TS3' and 'TSIII SA', are in fact the line and surface names that should be on your record.

Even so, the brand is the smaller half of the question. Most of Osstem's lines are conventional two-piece implants: they sit in the inner part of the bone and need enough volume there. The implant used in our protocol of fixed teeth in 72 hours with the Ihde method belongs to a different class: a one-piece corticobasal implant that anchors in the hard outer layer of the jaw. Which one suits you is decided by the bone on your CBCT scan.

The criteria below do not depend on the name of the line; they look at the conventional two-piece implant design and can be discussed at your consultation.

They are short questions, but their answers put on record today the information that will be useful to you years from now.

1. 1

   Which line will be used?

   TS, KS, ET, SS or MS. Will it sit at bone level or at gum level? It should be possible to explain the choice in terms of the density, width and height of your bone.

2. 2

   Which surface and which platform?

   Surface names such as SA, BA, SOI or NH, and the diameter and platform. These are what separate the different product codes of the same line.

3. 3

   What tightening torque will the abutment screw be secured with?

   Laboratory data show that loosening varies with the screw design and the tightening torque. Having the torque used put on record is useful if loosening is being discussed later.

4. 4

   Can I see the barcode on the label?

   Medical devices put on the market in Turkey must be registered in the Product Tracking System (ÜTS). The number on the label shows the product's manufacturer and its registration.

5. 5

   Where do parts come from, and how long do they take?

   Osstem is represented in Turkey under the name Osstem Implant Türkiye. Ask whether the clinic has parts in stock and, if not, how long it takes to obtain them.

If the first four points below are in place, the difference between brands narrows; if they are not, no brand makes up for the gap.

The sheer number of line names and a different brand name in the USA produce a few misleading shortcuts online.

Nobody asks for these documents today; but years from now, in another dentist's chair, they will be the first thing you are asked for.

1. An implant card with the name of the line

   The card should say more than just 'Osstem': it should give the line and surface name, such as TSIII SA or KSIII, together with the diameter, platform, length and lot number. If anything is missing, ask the clinic that carried out the treatment to complete it.

2. Torque values

   The insertion torque and the tightening torque of the abutment screw. If screw loosening is being discussed, these are the only record showing what was done at the start.

3. A copy of the barcode

   The barcode on the product label carries the number that identifies the implant in ÜTS. Keep it together with your card.

4. The X-ray from the first day

   The X-ray that shows where your bone level was at the start. Only with it can any change be read when it is compared with an X-ray taken years later.

The implant's country does not explain the difference in a quote on its own. The total is made up of these items:

Choice of line and surface

Within the same brand, lines and surfaces can differ in cost. Check which line is written in the quote; the phrase 'Osstem implant' is not enough on its own.

Top parts

Ready-made parts, patient-specific parts or parts for a multi-unit prosthesis make more difference than the implant body in most plans.

The prosthesis and laboratory work

In full-mouth plans, the material and workmanship of the bridgework make up most of the total. This is the last place where savings should be made.

Preparatory procedures and later maintenance

A graft, a sinus procedure or extractions are separate items. The burden of repairs over the years depends on how easily parts can be obtained.